Home > Cashflow Statement > TRIDENT LIFELINE

TRIDENT LIFELINE
Cashflow Statement

COMMUNITY POLL
for TRIDENT LIFELINE
Please provide your vote to see the results

TRIDENT LIFELINE Last 5 Year Cashflow Statement History

[Consolidated]

Mar2023Mar2022
Profit Before Tax₹6.58 Cr₹2.98 Cr
Adjustment ₹0.08 Cr₹0.33 Cr
Changes In working Capital ₹-24 Cr₹-3.67 Cr
Cash Flow after changes in Working Capital ₹-17 Cr₹-0.36 Cr
Cash Flow from Operating Activities ₹-17 Cr₹-0.21 Cr
Cash Flow from Investing Activities ₹-6.94 Cr₹-0.45 Cr
Cash Flow from Financing Activities ₹38 Cr₹0.80 Cr
Net Cash Inflow / Outflow ₹14 Cr₹0.14 Cr
Opening Cash & Cash Equivalents ₹0.16 Cr₹0.01 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger --
Cash & Cash Equivalent of Subsidiaries under liquidations --
Translation adjustment on reserves / op cash balalces frgn subsidiaries --
Effect of Foreign Exchange Fluctuations --
Closing Cash & Cash Equivalent ₹14 Cr₹0.16 Cr

Compare Cashflow Statement of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹194.4 Cr -4.5% 5.6% 14.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,290.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹113,357.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹111,134.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹104,235.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,001.5 Cr -1% -2.4% 28.4% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

-4.5%

5.6%

14.4%

SENSEX

1.7%

1.5%

18.7%


You may also like the below Video Courses